Next Article in Journal
The Good, the Bad, and the Ugly of Pregnancy Nutrients and Developmental Programming of Adult Disease
Previous Article in Journal
Specific Collagen Peptides in Combination with Resistance Training Improve Body Composition and Regional Muscle Strength in Premenopausal Women: A Randomized Controlled Trial
Previous Article in Special Issue
A Metabolomics Approach to the Identification of Urinary Biomarkers of Pea Intake
 
 
Article
Peer-Review Record

Potential Nutritional and Metabolomic Advantages of High Fat Oral Supplementation in Pancreatectomized Pancreaticobiliary Cancer Patients

Nutrients 2019, 11(4), 893; https://doi.org/10.3390/nu11040893
by Bo Kyeong Yun 1,†, Mina Song 1,†, Ho Kyoung Hwang 2, Hosun Lee 3, Song Mi Lee 3, Chang Moo Kang 2,* and Seung-Min Lee 1,*
Reviewer 1: Anonymous
Reviewer 2: Anonymous
Nutrients 2019, 11(4), 893; https://doi.org/10.3390/nu11040893
Submission received: 23 March 2019 / Accepted: 18 April 2019 / Published: 20 April 2019
(This article belongs to the Special Issue Metabolomics in Nutrition)

Round  1

Reviewer 1 Report

REVIEW                                                                               

Manuscript: Potential nutritional and metabolomics advantages of high fat oral supplementation in pancreatectomized pancreaticobiliary cancer patients.

Dear Authors,

The authors report on the influence of high fat oral supplementation on the outcome in pacreaticobiliry cancer patients.  It is an interesting presentation and important topic for clinicians due to the increasing incidence of pancreaticobiliary cancer with dismal prognosis.

The number of patients with n = 25  is small however the design of the study, the laboratory work-up and results  are significant and completed by excellent tables and figures.

Reviewer 2 Report

This study by Yun and colleagues represents a valuable contribution to the field of nutrition in (operated) pancreatic cancer patients with the analysis of the metabolism. Although this is a small, hence exploratory study, the results are sound and well presented. The only real criticism would be that obviously surgery as such is greatly affecting the metabolism. Therefore, two additional groups (unoperatyed PDAC patients +/- HFS) would be  in place

Back to TopTop